These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 3246192)

  • 1. [The diagnostic value of platelet malondialdehyde/malondialdehyde-a in blood in hypercoagulable states and thrombotic diseases].
    Zheng RL; Zhang GZ; Sun LY
    Zhonghua Nei Ke Za Zhi; 1988 Nov; 27(11):683-5, 716-7. PubMed ID: 3246192
    [No Abstract]   [Full Text] [Related]  

  • 2. Platelet malonyldialdehyde and spontaneous aggregation during ischaemic attacks of patients with polycythaemia vera.
    Cortelazzo S; Barbui T; Viero P; Bassan R; Dini E; Ferro Milone F
    Thromb Haemost; 1979 Dec; 42(4):1344-6. PubMed ID: 542939
    [No Abstract]   [Full Text] [Related]  

  • 3. Platelet malonyldialdehyde formation: an indicator of platelet hyperfunction.
    Stuart MJ
    Thromb Haemost; 1979 Aug; 42(2):649-54. PubMed ID: 505371
    [No Abstract]   [Full Text] [Related]  

  • 4. Influence of leukotriene C4 on aggregation and on malondialdehyde formation of human blood platelets.
    Pönicke K; Förster W
    Biomed Biochim Acta; 1984; 43(8-9):S459-62. PubMed ID: 6440558
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential inhibition of prostacyclin production and platelet aggregation by aspirin in humans.
    Masotti G; Galanti G; Poggesi L; Abbate R; Neri Serneri GG
    Adv Prostaglandin Thromboxane Res; 1980; 6():317-20. PubMed ID: 6992529
    [No Abstract]   [Full Text] [Related]  

  • 6. [Effect of temperature and preservation time on the aggregation and MDA level of blood platelets].
    Stachecki B; Kaszkowiak M; Kotelba-Witkowska B; Jakuboszczak E; Fenrych W
    Acta Haematol Pol; 1986; 17(3-4):122-30. PubMed ID: 3591238
    [No Abstract]   [Full Text] [Related]  

  • 7. [Clinical significance of determining circulatory platelet aggregates in thrombotic diseases].
    Zhang GZ
    Zhonghua Yi Xue Za Zhi; 1984 Jul; 64(7):417-9. PubMed ID: 6440682
    [No Abstract]   [Full Text] [Related]  

  • 8. [Formation of platelet malondialdehyde in hypertensive patients subjected to cycloergometric exercise tests].
    Davì G; Novo S; Riolo F; Pinto A; Mendola G; Mazzola A; Fazio M
    Boll Soc Ital Cardiol; 1980; 25(10):1167-72. PubMed ID: 7326120
    [No Abstract]   [Full Text] [Related]  

  • 9. [Lipid peroxides and thrombosis].
    Kubatiev AA; Andreev SV
    Biull Eksp Biol Med; 1979 May; 87(5):414-7. PubMed ID: 454816
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence on thromboxane and malondialdehyde synthesis in human thrombocytes by various inhibitors of platelet function.
    Busse WD; Seuter F
    Agents Actions Suppl; 1979; (4):127-37. PubMed ID: 291303
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thrombin-induced platelet malondialdehyde (MDA) formation in normal subjects and in women taking oral contraceptives.
    Hellstern P; Miyashita C; Köhler M; Wenzel E; Holl W
    Thromb Haemost; 1982 Dec; 48(3):325-6. PubMed ID: 7164021
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Serum levels of malondialdehyde and antioxidant activity in patients with chronic renal failure].
    Asaka S
    Nihon Jinzo Gakkai Shi; 1986 Oct; 28(10):1359-70. PubMed ID: 3820812
    [No Abstract]   [Full Text] [Related]  

  • 13. The effect of certain antiplatelet drugs on in vitro malonylaldehyde (MDA) production.
    Fabris F; Casonato A; De Marco L; Girolami A
    Arzneimittelforschung; 1979; 29(7):981-3. PubMed ID: 583000
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Changes in platelet production of malondialdehyde in diabetics treated with dilazep].
    Carleo R; Buda GR; Cerciello A; Dell'Aversano R; Monaco GP; Trovato C; Vigilante M
    Boll Soc Ital Biol Sper; 1983 Dec; 59(12):1838-41. PubMed ID: 6671043
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Platelet malondialdehyde and plasma thromboxane B2 formation in patients with obliterative arteriosclerosis of the lower limbs.
    Bodzenta A; Bielawiec M; Krupiński K; Wojtukiewicz M
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1982; 109(5):804-7. PubMed ID: 6188668
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma malonaldehyde levels during myocardial infarction.
    Dousset JC; Trouilh M; Foglietti MJ
    Clin Chim Acta; 1983 Apr; 129(3):319-22. PubMed ID: 6851170
    [No Abstract]   [Full Text] [Related]  

  • 17. [Observations on levels of TXA2 and PGI2 and the generation of platelet MDA in patients with chronic cor pulmonale].
    Zhou YC
    Zhonghua Jie He He Hu Xi Za Zhi; 1987 Apr; 10(2):80-2, 123-4. PubMed ID: 3319212
    [No Abstract]   [Full Text] [Related]  

  • 18. Activation of platelets in patients with chronic proliferative glomerulonephritis and the nephrotic syndrome.
    Tomura S; Ida T; Kuriyama R; Chida Y; Takeuchi J; Motomiya T; Yamazaki H
    Clin Nephrol; 1982 Jan; 17(1):24-30. PubMed ID: 6459902
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hematocrit in thrombotic stroke at Ramathibodi Hospital.
    Jootar S; Withoonpanich R; Niramarnsakul S
    J Med Assoc Thai; 1989 Feb; 72(2):97-100. PubMed ID: 2738492
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polycythemia vera and mesenteric arterial thrombosis. A disease association resulting from decreased platelet sensitivity to aspirin.
    Myers TJ; Steinberg WM; Rickles FR
    Arch Intern Med; 1979 Jun; 139(6):695-8. PubMed ID: 443976
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.